NCT04137263View on ClinicalTrials.gov

Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2019

Primary Completion Date

October 1, 2020

Study Completion Date

December 1, 2020

Conditions
Melasma
Interventions
OTHER

DOSE formulation

over-the-counter topical

Trial Locations (1)

92121

Cosmetic Laser Dermatology, San Diego

All Listed Sponsors
collaborator

L'Oreal

INDUSTRY

lead

Goldman, Butterwick, Fitzpatrick and Groff

OTHER

NCT04137263 - Study Evaluating the Efficacy of DOSE Formulations in Treating Melasma and Cutaneous Signs of Aging | Biotech Hunter | Biotech Hunter